Discovery of Drugs for diabetic complications

Endocrinology

Rapid effect Low recurrence rate Non toxicity

Project Team

KT
ken takabashi

Institutions

OP
ODA PHARM
JP

Project Status

Clinical Stage
Preclinical
Patent Status
Patent not filed

Funding Opportunity

Opportunity type
Funding requested
$900,000
Funding allocated
$0

Background

So far, all the traditional treatment plans are aimed at delaying the deterioration of diabetes, and there is no cure plan. Without effective treatment, diabetic patients will eventually face the fatal threat from diabetic microvascular complications and diabetic macro-vascular complications.

Project Details

More than 97.75% of the patients confirmed the disappearance of body sensation in the skin pruritus, insomnia, weakness and other common complications. 82.36% of the patients in the 90 day follow-up examination report, the daily blood glucose value, glycosylated hemoglobin value decreased. The dosage of insulin for injection decreased, and the data of retinopathy, nephropathy and other laboratory reports showed improvement.

Project Timeline

  • Increase the activity of active ingredients

    Required Funding$900,000
    Statusongoing
    Duration10 Months

    The active ingredient will be wrapped by a protease and released slowly after entering the digestive system, improving the absorption efficiency and enhancing the effect. Preliminary experiments have been completed on mice.